References
- Graffigna G, Palamenghi L, Barello S, Stefania B. “Cultivating” acceptance of a COVID-19 vaccination program: lessons from Italy. Vaccine. 2020;38(48):7585–86. doi:10.1016/j.vaccine.2020.10.025.
- Graffigna G, Barello S, Bonanomi A, Cipresso P. The role of Patient Health Engagement model (PHE-model) in affecting patient activation and medication adherence: a structural equation model. PLoS One. 2017;12(6):e0179865. doi:10.1371/journal.pone.0179865.
- Batterham RW, Hawkins M, Collins PA, Buchbinder R, Osborne RH. Health literacy: applying current concepts to improve health services and reduce health inequalities. Public Health. 2016;132:3–12. doi:10.1016/j.puhe.2016.01.001.
- MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, Goldstein S, Larson H, Manzo ML, Reingold A, et al. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.
- Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, et al. Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago. Intern Emerg Med. 2017;12(8):1109–19. doi:10.1007/s11739-017-1678-9.
- Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–67. doi:10.7326/0003-4819-146-12-200706190-00007.
- Magon A, Arrigoni C, Moia M, Mancini M, Dellafiore F, Manara DF, Caruso R. Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using Vitamin K antagonists. Health Qual Life Outcomes. 2020;18(1). doi:10.1186/s12955-020-01326-y.
- Palareti G, Antonucci E, Legnani C, Mastroiacovo D, Poli D, Prandoni P, Tosetto A, Pengo V, Testa S, Ageno W. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register. BMJ Open. 2020;10(11):e040449. doi:10.1136/bmjopen-2020-040449.
- SISET. Vaccinazioni anti covid-19 per pazienti con trombosi/trombofilia: indicazioni pratiche. Siset 2021. [accessed 2021 Aug 28]. https://www.siset.org/?option=com_content&view=article&id=339 .
- Poli D, Chiarugi L, Capanni M, Antonucci E, Abbate R, Gensini G, Prisco D. Need of more frequent international normalized ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis. 2002;13(4):297–300. doi:10.1097/00001721-200206000-00004.
- Iorio AM, Camilloni B, Basileo M, Guercini F, Conti S, Ferrante F, Paccamiccio E, Iaboni S, Vecchioli M, Iorio A. Influenza vaccination in patients on long-term anticoagulant therapy. Vaccine. 2006;24(44–46):6624–28. doi:10.1016/j.vaccine.2006.05.036.
- Barello S, Palamenghi L, Graffigna G. The mediating role of the patient health engagement model on the relationship between patient perceived autonomy supportive healthcare climate and health literacy skills. Int J Environ Res Public Health. 2020;17(5):1–13. doi:10.3390/ijerph17051741.
- Graffigna G, Palamenghi L, Boccia S, Barello S. Relationship between citizens’ health engagement and intention to take the covid-19 vaccine in Italy: a mediation analysis. Vaccines. 2020;8(4):1–11. doi:10.3390/vaccines8040576.
- Kongsved SM, Basnov M, Holm-Christensen K, Hjollund NH. Response rate and completeness of questionnaires: a randomized study of internet versus paper-and-pencil versions. J Med Internet Res. 2007;9(3):e25. doi:10.2196/jmir.9.3.e25.
- Eysenbach G. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi:10.2196/jmir.6.3.e34.
- Lorini C, Lastrucci V, Mantwill S, Vettori V, Bonaccorsi G. Measuring health literacy in Italy: a validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in florence and its surroundings. Ann Ist Super Sanità. 2019;55:10–18.
- Graffigna G, Barello S, Bonanomi A, Lozza E. Measuring patient engagement: development and psychometric properties of the Patient Health Engagement (PHE) scale. Front Psychol. 2015;6:274. doi:10.3389/fpsyg.2015.00274.
- Burgess RA, Osborne RH, Yongabi KA, Greenhalgh T, Gurdasani D, Kang G, Falade AG, Odone A, Busse R, Martin-Moreno JM, et al. The COVID-19 vaccines rush: participatory community engagement matters more than ever. Lancet. 2021;397(10268):8–10. doi:10.1016/S0140-6736(20)32642-8.
- Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother. 2018;14(7):1609. doi:10.1080/21645515.2018.1459252.
- Reno C, Maietti E, Fantini MP, Savoia E, Manzoli L, Montalti M, Gori D. Enhancing COVID-19 vaccines acceptance: results from a survey on vaccine hesitancy in Northern Italy. Vaccines. 2021;9(4):378. doi:10.3390/vaccines9040378.
- Robertson E, Reeve KS, Niedzwiedz CL, Moore J, Blake M, Green M, Katikireddi SV, Benzeval MJ. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:50. doi:10.1016/j.bbi.2021.03.008.
- Turhan Z, Dilcen HY, Dolu İ. The mediating role of health literacy on the relationship between health care system distrust and vaccine hesitancy during COVID-19 pandemic. Curr Psychol. 2021;1–10.
- Biasio LR, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Human Vaccines & Immunotherapeutics. 2020;17:1304–12. doi:10.1080/2164551520201829315.
- Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2021;1–8. [accessed 2021 Aug 28]. https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1950504 .
- SISET SIGU Indicazioni sulla prescrizione di test genetici per trombofilia [Internet]; 2021. [accessed 2021 Aug 28]. http://www.siset.org/congressi/2-non-categorizzato/345-la-societa-italiana-per-lo-studio-emostasi-e-trombosi-siset-e-la-societa-italiana-di-genetica-umana-sigu-su-vaccinazione-per-covid-19-e-rischio-di-eventi-trombotici-indicazioni-sulla-prescrizione-di-t .
- SISET, SIGU. Indicazioni sulla prescrizione di test genetici per trombofilia. 2021. [accessed 2021 Aug 28]. http://www.siset.org/congressi/2-non-categorizzato/345-la-societa-italiana-per-lo-studio-emostasi-e-trombosi-siset-e-la-societa-italiana-di-genetica-umana-sigu-su-vaccinazione-per-covid-19-e-rischio-di-eventi-trombotici-indicazioni-sulla-prescrizione-di-t .